| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/26/2006 | US7112405 Compositions and methods for enhancing oligonucleotide-mediated gene alteration |
| 09/26/2006 | US7112404 Process for high throughput DNA methylation analysis |
| 09/26/2006 | US7112324 CD 19×CD3 specific polypeptides and uses thereof |
| 09/26/2006 | US7112281 Underdrain for filtration membrane |
| 09/26/2006 | US7111493 Combustible gas detection system |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/26/2006 | CA2260095C Process and device for carrying out quantitative, fluorescence affinity tests |
| 09/25/2006 | CA2535095A1 Differentiation and identification of analogous chemical or biological substances with biosensors |
| 09/24/2006 | CA2539281A1 Methods for the treatment of insulin resistance and disease states characterized by insulin resistance |
| 09/24/2006 | CA2533961A1 Method for processing a set of spectra, particularly nmr spectra |
| 09/21/2006 | WO2006099623A2 Methods and compositions to diagnose disease using concatenated oligopeptide standard |
| 09/21/2006 | WO2006099620A2 Rage/diaphanous interaction and related compositions and methods |
| 09/21/2006 | WO2006099549A2 Filtration tester and method for predicting to which extent a printing ink would lead to a clogging of a printer nozzle |
| 09/21/2006 | WO2006099544A2 Apparatus and method for computer modeling type 1 diabetes |
| 09/21/2006 | WO2006099543A2 Methods for assessing antibody-mediated cytotoxicity |
| 09/21/2006 | WO2006099537A2 The use of antibody-surrogate antigen systems for detection of analytes |
| 09/21/2006 | WO2006099493A2 Rapidly detecting and quantifying viable legionella |
| 09/21/2006 | WO2006099432A1 Metabonomics homogeneity analysis |
| 09/21/2006 | WO2006099377A1 Methods for detecting alzheimer's disease |
| 09/21/2006 | WO2006099185A2 Brsk1s as modifiers of the pten/akt pathway and methods of use |
| 09/21/2006 | WO2006099183A2 Nek8s as modifiers of the pten/akt pathway and methods of use |
| 09/21/2006 | WO2006099182A2 Mptenakts as modifiers of the pten/akt pathway and methods of use |
| 09/21/2006 | WO2006099181A2 Eef2k as modifiers of the pten/akt pathway and methods of use |
| 09/21/2006 | WO2006099126A2 Biomarkers for ovarian cancer and endometrial cancer: hepcidin |
| 09/21/2006 | WO2006098987A2 Methods of inhibiting angiogenesis and tumor development |
| 09/21/2006 | WO2006098925A1 Inspection system and apparatus |
| 09/21/2006 | WO2006098803A1 Lateral flow devices using reactive chemistry |
| 09/21/2006 | WO2006098769A2 Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers |
| 09/21/2006 | WO2006098744A2 Ifbm’s to promote attachment of target analytes |
| 09/21/2006 | WO2006098612A1 Method for determining an allergic response |
| 09/21/2006 | WO2006098523A1 Evaluation method for skin condition utilizing squamous cell carcinoma-related antigen as measure |
| 09/21/2006 | WO2006098520A1 Screening method |
| 09/21/2006 | WO2006098488A1 Method of ameliorating symptom caused by mood disturbance |
| 09/21/2006 | WO2006098464A1 Method for diagnosis of prostate cancer |
| 09/21/2006 | WO2006098435A1 Detecting chip and method of detecting substance using the same |
| 09/21/2006 | WO2006098401A1 Method for determination of risk of rheumatoid arthritis |
| 09/21/2006 | WO2006098350A1 Blood coagulation accelerator and vessel for blood test |
| 09/21/2006 | WO2006098297A1 Sampling liquid container |
| 09/21/2006 | WO2006098192A1 Biocondition evaluating device, biocondition evaluating method, biocondition evaluating system, biocondition evaluating program, evaluation function generating device, evaluation function generating method, evaluation function generating program, and recording medium |
| 09/21/2006 | WO2006098144A1 Detection marker, detection kit and detection method for idiopathic pulmonary fibrosis |
| 09/21/2006 | WO2006098087A1 Marker protein for use in diagnosis of pancreatic cancer |
| 09/21/2006 | WO2006097773A1 Screening method for compounds with anaesthetic property |
| 09/21/2006 | WO2006097716A1 Compliance apparatus |
| 09/21/2006 | WO2006097688A1 Measuring near infra-red spectra using a demountable nir transmission cell |
| 09/21/2006 | WO2006097631A1 Method and device for isolating micro-organisms |
| 09/21/2006 | WO2006097382A1 Method and device for measuring the viscosity of non-newtonian liquids, in particular motor fuels |
| 09/21/2006 | WO2006097336A2 A novel component of the wg/wnt signaling pathway |
| 09/21/2006 | WO2006097335A1 A new element of the wg/wnt signaling pathway |
| 09/21/2006 | WO2006097288A1 Nutritional compositions for modulating vitamin c bio-availability |
| 09/21/2006 | WO2006097244A2 Methods for assessing emphysema |
| 09/21/2006 | WO2006096988A1 Method for characterizing cell surface charge |
| 09/21/2006 | WO2006096953A1 Use of crotamine, kit and composition |
| 09/21/2006 | WO2006084018A3 Methods for determining responsiveness to cancer therapy |
| 09/21/2006 | WO2006083651A3 High throughput screening of solubility for compounds in different excipients |
| 09/21/2006 | WO2006079334A3 Protein identifying and quantifying method |
| 09/21/2006 | WO2006077241A3 Kringle domains in a calcium sensor fusion protein |
| 09/21/2006 | WO2006063462A9 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/21/2006 | WO2006059125A3 Tumour suppressor genes |
| 09/21/2006 | WO2006058300A3 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 09/21/2006 | WO2006053251A3 Method of measuring amyloid-beta peptides |
| 09/21/2006 | WO2006049957A3 Method for treating glioma |
| 09/21/2006 | WO2006046964A3 High-temperature gas sensors and their use in exhaust gases |
| 09/21/2006 | WO2006045037A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 09/21/2006 | WO2006043182A3 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 09/21/2006 | WO2006040373B1 Identification of dna in raw or processed foods and compound feeds |
| 09/21/2006 | WO2006035066A3 Toll-like receptor 3, its signalling associated molecule trif and their use in the prevention and treatment of host inflammation response induced by a rna virus |
| 09/21/2006 | WO2006033022A3 Repair and protection factor scoring method for bioactive agents |
| 09/21/2006 | WO2006027206A3 In vitro method for the diagnosis of acute leukaemia |
| 09/21/2006 | WO2006026581A3 TIMING OF OVULATION BASED ON VAGINAL pH |
| 09/21/2006 | WO2006023635A3 Methods of screening proteins |
| 09/21/2006 | WO2006021549A3 Method for the identification of atypical p-anca |
| 09/21/2006 | WO2006020936A3 A method for assessing disease states by profile analysis of isolated circulating endothelial cells |
| 09/21/2006 | WO2006017181A3 Methods and systems for predicting protein-ligand coupling specificities |
| 09/21/2006 | WO2006004958A3 Detection or measurement of antibodies to antigenic proteins in biological tissues or samples |
| 09/21/2006 | WO2005112988B1 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 09/21/2006 | WO2005098424A8 Method and apparatus for implementing threshold based correction functions for biosensors |
| 09/21/2006 | WO2005082095A3 Method and apparatus for measuring properties of concrete |
| 09/21/2006 | WO2005044794A3 Immunohistochemical methods |
| 09/21/2006 | WO2005037053A3 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 09/21/2006 | WO2005033657A3 Automated cytological sample classification |
| 09/21/2006 | WO2005027714A3 Sensitive and rapid biodetection |
| 09/21/2006 | WO2005026321A3 Protein o-sulfonation |
| 09/21/2006 | WO2005003730A3 Sensors |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/21/2006 | US20060212957 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1 |
| 09/21/2006 | US20060212956 Animal model of ligand activated HER2 expressing tumors |
| 09/21/2006 | US20060212953 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 09/21/2006 | US20060212229 Method and system for providing a probe array chip design database |
| 09/21/2006 | US20060211624 Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211151 Methods for fabricating separation apparatus |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211148 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211147 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211146 Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211145 Diagnostic for insulin resistance |
| 09/21/2006 | US20060211144 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |